Chemical Dependency MAT Program
Addiction is a disease that can drastically interfere with an individual’s work and home settings. Chemical dependency treatment is crucial to recovery from addiction to drugs or alcohol.
Arrowhead Behavioral Health offers medication-assisted treatment (MAT) for adults struggling with acute symptoms of alcohol or drug addiction.
Our MAT program utilizes FDA-approved medications, counseling and behavioral health services. This treatment approach is intended to help patients detox with as minimal discomfort as possible in a confidential setting.
Suboxone® Treatment Program
For individuals suffering from opiate dependence, Arrowhead Behavioral Health offers a Suboxone treatment program. Suboxone is a prescription medication that is used to treat addiction to heroin and other opiates. The Suboxone program at Arrowhead Behavioral Health is a supervised medical detox that supports a healthy addiction recovery.
Suboxone is a combination of Buprenorphine and Naloxone, and the leading drug of choice to treat opiate dependence in the non-federal setting. The Buprenorphine component of Suboxone is a “partial” opiate capable of satisfying the body’s need for narcotics, but does not cause the euphoria or dangerous respiratory depression of “full” opiates. The Naloxone component cancels the opiate effect of Buprenorphine if Suboxone is misused by snorting or IV injection; therefore, Suboxone has far less abuse potential.
Components of Suboxone Treatment Program
- Individualized treatment regimen
- Certified psychiatrist to oversee treatment
- Medically supervised detox
- Increases chances of sustaining abstinence
- Can be used on a maintenance basis for weeks to months, while the patient stabilizes their emotional, physical and mental well being
Stages of Suboxone Treatment
Induction – Patients are psychologically and physiologically assessed for candidacy to receive the first doses of Suboxone on an inpatient basis. The patient is observed for adverse effects and medicated with enough Suboxone to control withdrawal symptoms. This period usually lasts one to three days. Many patients have medical and psychiatric complications that make induction best achieved in an inpatient setting.
Stabilization – The patient’s dose of Suboxone is adjusted to their own therapeutic level that alleviates withdrawal and cravings that may lead to relapse. Utilizing a partial hospitalization or intensive outpatient program, the patient engages in psychosocial counseling and urine testing to ensure compliance. Stabilization typically takes two days to four weeks.
Maintenance – Patients continue on appropriate dosage of Suboxone while attending weekly group therapy sessions. Urine testing and Suboxone prescriptions are used to help secure stability of recovery. This stage is individualized and can last weeks to months.
Detoxification – Medically supervised discontinuation of Suboxone can occur immediately after a brief induction and stabilization, or slowly after an individualized maintenance of appropriate length. Supportive treatment during and after detox is encouraged.
